Keyphrases
Vaccination
100%
Th1-like
100%
Pseudomonas Aeruginosa Pneumonia
100%
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Inflammation
100%
Cystic Fibrosis
62%
Alginate
62%
Depolymerizing
50%
Inflammatory Response
25%
Lung Infection
25%
Rat Model
25%
Interferon-γ
25%
O-polysaccharide
12%
Vaccine Strategy
12%
Elastase
12%
Gamma Treatment
12%
Supernatant
12%
Chronic Inflammation
12%
Lung Histology
12%
Chronic Lung Inflammation
12%
One Year Period
12%
First Week
12%
Polymorphonuclear Leukocytes
12%
Concanavalin A (Con A)
12%
Spleen Cells
12%
Interleukin-4 (IL-4)
12%
Mononuclear Leukocytes
12%
Lung Tissue Damage
12%
Chronic Infection
12%
Lung Inflammation
12%
Healthy Lung
12%
Chronic Lung Infection
12%
Bacterial Clearance
12%
Lung
12%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Pseudomonas aeruginosa
100%
Pseudomonas Pneumonia
100%
Cystic Fibrosis
55%
Alginic Acid
55%
C3H/He Mouse
55%
Lung Infection
33%
Rat Model
22%
Infection
22%
Pneumonia
22%
Chronic Inflammation
11%
Concanavalin A
11%
Interleukin 4
11%
Tissue Injury
11%
C3H Mouse
11%
Elastase
11%
Bacterial Clearance
11%
Inbred Mouse Strain
11%
Polysaccharide
11%
Immunology and Microbiology
Pseudomonas aeruginosa
100%
C3H/He Mouse
50%
Granulocyte
30%
Pulmonary Inflammation
20%
Rat Model
20%
Inflammation Response
20%
C3H Mouse
10%
Concanavalin A
10%
Conjugate
10%
Splenocyte
10%
Interleukin 4
10%
Peripheral Blood Mononuclear Cell
10%
Bacterial Clearance
10%
Inbred Mouse Strain
10%